Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Representing the Process of Inflammation as Key Events in Adverse Outcome Pathways.
Villeneuve DL, Landesmann B, Allavena P, Ashley N, Bal-Price A, Corsini E, Halappanavar S, Hussell T, Laskin D, Lawrence T, Nikolic-Paterson D, Pallardy M, Paini A, Pieters R, Roth R, Tschudi-Monnet F. Villeneuve DL, et al. Among authors: pallardy m. Toxicol Sci. 2018 Jun 1;163(2):346-352. doi: 10.1093/toxsci/kfy047. Toxicol Sci. 2018. PMID: 29850905 Free PMC article. Review.
Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification.
Germolec DR, Lebrec H, Anderson SE, Burleson GR, Cardenas A, Corsini E, Elmore SE, Kaplan BLF, Lawrence BP, Lehmann GM, Maier CC, McHale CM, Myers LP, Pallardy M, Rooney AA, Zeise L, Zhang L, Smith MT. Germolec DR, et al. Among authors: pallardy m. Environ Health Perspect. 2022 Oct;130(10):105001. doi: 10.1289/EHP10800. Epub 2022 Oct 6. Environ Health Perspect. 2022. PMID: 36201310 Free PMC article.
State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop.
van Vliet E, Kühnl J, Goebel C, Martinozzi-Teissier S, Alépée N, Ashikaga T, Blömeke B, Del Bufalo A, Cluzel M, Corsini E, Delrue N, Desprez B, Gellatly N, Giese C, Gribaldo L, Hoffmann S, Klaric M, Maillere B, Naisbitt D, Pallardy M, Vocanson M, Petersohn D. van Vliet E, et al. Among authors: pallardy m. ALTEX. 2018;35(2):179-192. doi: 10.14573/altex.1709011. Epub 2017 Oct 2. ALTEX. 2018. PMID: 28968481 Free article.
In vitro tests to evaluate immunotoxicity: a preliminary study.
Carfi' M, Gennari A, Malerba I, Corsini E, Pallardy M, Pieters R, Van Loveren H, Vohr HW, Hartung T, Gribaldo L. Carfi' M, et al. Among authors: pallardy m. Toxicology. 2007 Jan 5;229(1-2):11-22. doi: 10.1016/j.tox.2006.09.003. Epub 2006 Sep 10. Toxicology. 2007. PMID: 17092623
The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop.
Gennari A, Ban M, Braun A, Casati S, Corsini E, Dastych J, Descotes J, Hartung T, Hooghe-Peters R, House R, Pallardy M, Pieters R, Reid L, Tryphonas H, Tschirhart E, Tuschl H, Vandebriel R, Gribaldo L. Gennari A, et al. Among authors: pallardy m. J Immunotoxicol. 2005 Apr 1;2(2):61-83. doi: 10.1080/15476910590965832. J Immunotoxicol. 2005. PMID: 18958661 Free article.
Th(1)/Th(2) responses to drugs.
Lebrec H, Kerdine S, Gaspard I, Pallardy M. Lebrec H, et al. Among authors: pallardy m. Toxicology. 2001 Feb 2;158(1-2):25-9. doi: 10.1016/s0300-483x(00)00398-x. Toxicology. 2001. PMID: 11164989 Review.
182 results